Barings LLC Gilead Sciences, Inc. Transaction History

Barings LLC

$4.08 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $136,565 - $153,813	2,366 Added 32.07%	9,743 $602,000
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $427,275 - $535,422	7,377 New	7,377 $438,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $359,636 - $388,008	-5,313 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $33,067 - $36,131	-521 Reduced 8.93%	5,313 $365,000
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $34,860 - $39,775	-581 Reduced 9.06%	5,834 $377,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $3.59 Million - $4.09 Million	-63,381 Reduced 90.81%	6,415 $374,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $1.02 Million - $1.28 Million	-16,449 Reduced 19.07%	69,796 $4.41 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $277,137 - $354,973	-4,425 Reduced 4.88%	86,245 $6.45 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $1.3 Million - $1.43 Million	21,118 Added 30.36%	90,670 $5.89 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $373,934 - $412,758	-5,982 Reduced 7.92%	69,552 $4.41 Million
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $5.11 Million - $5.73 Million	-82,629 Reduced 52.24%	75,534 $5.1 Million
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $184,588 - $206,787	-2,952 Reduced 1.83%	158,163 $10.3 Million
Q4 2018 Feb 07, 2019	BUY	$60.54 - $79.0 $47,887 - $62,489	791 Added 0.49%	161,115 $10.1 Million
Q3 2018 Oct 26, 2018	SELL	$71.28 - $78.92 $737,249 - $816,269	-10,343 Reduced 6.06%	160,324 $12.4 Million
Q2 2018 Aug 03, 2018	BUY	$64.88 - $75.68 $1.41 Million - $1.65 Million	21,799 Added 14.64%	170,667 $12.1 Million
Q1 2018 May 04, 2018	BUY	$72.84 - $88.8 $861,842 - $1.05 Million	11,832 Added 8.63%	148,868 $11.2 Million
Q4 2017 Feb 08, 2018	BUY	$71.15 - $83.52 $1.39 Million - $1.63 Million	19,554 Added 16.64%	137,036 $9.82 Million
Q2 2017 Aug 15, 2017	SELL	N/A	-10,000 Reduced 7.84%	117,482 $8.32 Million
Q2 2017 Aug 14, 2017	BUY	N/A	127,482	127,482 $0

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barings LLC with notifications on news.

Account